Perfil
Umut Ulge is the founder of Neoleukin Therapeutics, Inc. which was founded in 2003.
He held the title of Vice President-Translational Medicine at the company.
Dr. Ulge received a doctorate degree from the University of Washington and UW Medicine.
Antiguos cargos conocidos de Umut Ulge.
| Empresas | Cargo | Fin |
|---|---|---|
| NEUROGENE INC. | Founder | 01/10/2021 |
Formación de Umut Ulge.
| University of Washington | Doctorate Degree |
| UW Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Umut Ulge
